Michelle P Chen, 35Los Angeles, CA

7351562, Apr 1, 2008

Apr 28, 2003

10/425332

Ranjini Chatterjee - Belmont CA, US
Michelle M. Chen - Belmont CA, US
Ranjan Patnaik - San Jose CA, US
Stephen L. Schmidt - Belmont MA, US

Codexis, Inc. - Redwood City CA

C12N 9/12
C12N 15/00
C12P 21/06
C07H 21/04

435189, 435 691, 4353201, 536 232

The present invention relates to novel ribulose-1,5-bisphosphate carboxylase/oxygenase polypeptides and the polynucleotides that encode them. The invention also provides related host cells and methods.

7745186, Jun 29, 2010

Mar 17, 2008

12/049839

Ranjini Chatterjee - Belmont CA, US
Michelle M. Chen - Belmont CA, US
Ranjan Patnaik - San Jose CA, US
Stephen L. Schmidt - Belmont MA, US

Codexis, Inc. - Redwood City CA

C12N 9/02
C12N 9/10
C12N 9/00
C12N 15/00
C12P 21/06
C07H 21/04

435189, 435193, 435232, 435183, 435 691, 4353201, 536 232

The present invention relates to novel ribulose-1,5-bisphosphate carboxylase/oxygenase polypeptides and the polynucleotides that encode them. The invention also provides related host cells and methods.

7790432, Sep 7, 2010

Oct 25, 2005

11/919271

Ranjini Chatterjee - Belmont CA, US
Kenneth W. Mitchell - San Jose CA, US
Susan Y. Louie - San Francisco CA, US
Richard J. Fox - Kirkwood MO, US
Michelle Chen - Moorpark CA, US

Codexis, Inc. - Redwood City CA

C12N 9/88
C12N 1/20
C12N 1/00
C12N 15/00
C07H 21/02

435232, 43525233, 4352541, 4353201, 536 231, 536 232

The present invention is directed to polypeptides that have enhanced alanine 2,3-aminomutase (AAM) activity and/or thermostability relative to the wild-type enzymes that have incidental AAM activity as a result of cross reactivity with alanine. In addition, the present invention is directed to a polynucleotides that encodes for the AAM polypeptides of the present invention, to nucleic acid sequences comprising the polynucleotides, to expression vectors comprising the polynucleotides operatively linked to a promoter, to host cells transformed to express the AAM polypeptides, and to a method for producing the AAM polypeptides of the present invention.

2022032, Oct 13, 2022

Dec 13, 2021

17/549772

- San Francisco CA, US
Kameron C. Chan - San Francisco CA, US
Alice Melocchi - Dalmine (BG), IT
Jeffrey Ackerman Curhan - Warwick RI, US
Michelle Chen - San Francisco CA, US
Nolan Dickey - San Francisco CA, US
Roger Lo - San Francisco CA, US
Lawrence Zachary Bright - Palo Alto CA, US
Sam Ihns - Cambridge MA, US
Umberto Scarfogliero - San Francisco CA, US

C12M 3/00
C12M 1/34

A docking device for receiving a portable device. The docking device includes a base including a substantially planar upper surface for supporting a portable device. The docking device includes an array of a plurality of engagement members. Each engagement member in the plurality of engagement members includes a fixed body protruding upwardly from the substantially planar upper surface of the base. Each engagement member includes a spring including a fixed end portion and a free end portion for engagement with the portable device. The fixed end portion interfaces with the fixed body. The free end portion protrudes from the fixed end portion obliquely towards the substantially planar upper surface of the base. The free end being movable along a deformable gap between a first surface of the fixed body and a second surface of the spring.

2023010, Mar 30, 2023

Feb 19, 2021

17/904471

- San Francisco CA, US
Kameron C. CHAN - San Francisco CA, US
Alice MELOCCHI - Dalmine, IT
Jeffrey Ackerman CURHAN - Warwick RI, US
Michelle CHEN - San Francisco CA, US
Nolan DICKEY - San Francisco CA, US
Roger Dean LO - San Francisco CA, US
Lawrence Zachary BRIGHT - Palo Alto CA, US

G05B 19/418

Systems and methods for implementing one or more compiled workflows at a biological foundry are provided. A representation of an uncompiled workflow to produce engineering targets is obtained. The representation is translated into a first corresponding instance of a compiled workflow. If the translation satisfaction of various threshold translation criteria is determined, and the first corresponding instance of the compiled workflow is executed to complete a first portion of manufacture of the engineering targets. If the executing satisfaction of various threshold execution criteria is determined, the representation is translated into a second corresponding instance of the compiled workflow different from the first corresponding instance. If this translation satisfaction of the various threshold translation criteria is determined, the second corresponding instance of the compiled workflow is executed to complete a second portion of the manufacture of the engineering targets.

2021032, Oct 21, 2021

Apr 19, 2021

17/234753

- San Francisco CA, US
Kameron C. Chan - San Francisco CA, US
Alice Melocchi - Dalmine (BG), IT
Jeffrey Ackerman Curhan - Warwick RI, US
Michelle Chen - San Francisco CA, US
Nolan Dickey - San Francisco CA, US
Roger Lo - San Francisco CA, US
Lawrence Zachary Bright - Palo Alto CA, US
Sam Ihns - Cambridge MA, US

C12M 3/00
C12M 1/34

A rigid cartridge for housing and removably coupling with a soft body bioreactor is provided. The rigid cartridge includes rigid walls defining a rigid housing. The rigid walls expose a fixed interior configured to house the soft body. An interior surface of a first rigid wall includes a first mating mechanism to engage a second mating mechanism of the soft body to removably coupled with the rigid cartridge and accommodate the soft body in the fixed interior of the rigid cartridge. A rigid wall includes a planar upper surface including an aperture. Each aperture is encompassed by an annular hood protruding upwardly from the substantially planar upper surface and integrally formed with the at least one rigid wall. The aperture is configured to receive and fixed engage a corresponding connector. Each connector includes a rigid coupling mechanism that provides communication with a corresponding plurality of ports of the soft body.

2021002, Jan 28, 2021

Oct 7, 2020

17/065485

- Palo Alto CA, US
Michelle YIP CHEN - San Mateo CA, US
Vikas SRIVASTAVA - Palo Alto CA, US

G06Q 40/04

Methods and apparatuses for generating and operating a swaps execution facility (SEP) compliant swaps trading platform are provided. In one example, a method for generating a SEP compliant swaps trading platform includes: (i) generating a swaps trading platform, wherein the generated swaps trading platform is configured to operate in accordance with a plurality of predefined rules associated with swaps execution facility (SEP) requirements; (ii) establishing one or more communication channels with respective one or more clearinghouses for transmission of clearinghouse information concerning one or more trade requests; and (iii) establishing one or more communication channels with respective one or more swaps data repository (SDR) providers for transmission of SDR information concerning the one or more trade requests.

2021002, Jan 28, 2021

Oct 7, 2020

17/065496

- Palo Alto CA, US
Michelle YIP CHEN - San Mateo CA, US
Vikas SRIVASTAVA - Palo Alto CA, US

G06Q 40/04

Methods and apparatuses for generating and operating a swaps execution facility (SEP) compliant swaps trading platform are provided. In one example, a method for generating a SEP compliant swaps trading platform includes: (i) generating a swaps trading platform, wherein the generated swaps trading platform is configured to operate in accordance with a plurality of predefined rules associated with swaps execution facility (SEP) requirements; (ii) establishing one or more communication channels with respective one or more clearinghouses for transmission of clearinghouse information concerning one or more trade requests; and (iii) establishing one or more communication channels with respective one or more swaps data repository (SDR) providers for transmission of SDR information concerning the one or more trade requests.